The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/20201
StudyName: Eligibility Colorectal Cancer NCT00469443
Date of export from the portal: 02.07.2020
Date of Upload / last change: 12.02.2017
License: Creative Commons BY 4.0

----

Description: 
Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC; ODM derived from: https://clinicaltrials.gov/show/NCT00469443
